Prostate Cancer clinical trials in Hawaii

2 actively recruiting prostate cancer trials at 5 sites across Hawaii.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting Academic/Other

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk …

Sponsor: NRG Oncology

NCT ID: NCT05946213

Sites in Hawaii:

Hawaii Cancer Care Inc - Waterfront Plaza — Honolulu, Hawaii
Queen's Cancer Cenrer - POB I — Honolulu, Hawaii
Queen's Medical Center — Honolulu, Hawaii
Straub Clinic and Hospital — Honolulu, Hawaii
University of Hawaii Cancer Center — Honolulu, Hawaii

View on ClinicalTrials.gov →

Phase 3 Recruiting Academic/Other

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

This phase III trial compares the effect of adding docetaxel to hormonal therapy and apalutamide versus hormonal therapy and apalutamide alone in treating patients with prostate cancer that has spread from where it first started (primary s…

Sponsor: Alliance for Clinical Trials in Oncology

NCT ID: NCT06931340

Sites in Hawaii:

Kaiser Permanente Moanalua Medical Center — Honolulu, Hawaii

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20